Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Whitney Barham

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Cellular Physiology|September 12, 2009
Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infectionLinda Connelly, Whitney Barham, Rachel Pigg, et al.
Breast Cancer Research : BCR|September 3, 2011
NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis modelLinda Connelly, Whitney Barham, Halina M Onishko, et al.
Cancer Research|October 23, 2014
Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune responseJinming Yang, Oriana E Hawkins, Whitney Barham, et al.
Cancer Immunology Research|August 18, 2025
A Dual Role for NKG7 in T-cell Cytotoxicity and LongevityHaidong Dong, Hyoungjun Ham, Whitney Barham, et al.
Immunohorizons|January 19, 2023
A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 InhibitorsWhitney Barham, Michelle Hsu, Xin Liu, et al.
BMC Cancer|October 8, 2020
Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancerAlyssa A Hoover, Demetra H Hufnagel, Whitney Harris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2016
p52 Overexpression Increases Epithelial Apoptosis, Enhances Lung Injury, and Reduces Survival after Lipopolysaccharide TreatmentJamie A Saxon, Dong-Sheng Cheng, Wei Han, et al.
Cancer Discovery|August 8, 2013
Targeting the Wnt pathway in synovial sarcoma modelsWhitney Barham, Andrea L Frump, Taylor P Sherrill, et al.
Journal for Immunotherapy of Cancer|October 28, 2025
Targeting PD-L1-CMTM6 interactions in myeloid cells triggers PD-L1 degradation and enhances cytotoxic T-cell expansionMichelle A Hsu, Xin Liu, Whitney Barham, et al.
Science Advances|June 26, 2018
Immunity drives <i>TET1</i> regulation in cancer through NF-κBEvelyne Collignon, Annalisa Canale, Clémence Al Wardi, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Cellular Physiology|September 12, 2009
Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infectionLinda Connelly, Whitney Barham, Rachel Pigg, et al.
Breast Cancer Research : BCR|September 3, 2011
NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis modelLinda Connelly, Whitney Barham, Halina M Onishko, et al.
Cancer Research|October 23, 2014
Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune responseJinming Yang, Oriana E Hawkins, Whitney Barham, et al.
Cancer Immunology Research|August 18, 2025
A Dual Role for NKG7 in T-cell Cytotoxicity and LongevityHaidong Dong, Hyoungjun Ham, Whitney Barham, et al.
Immunohorizons|January 19, 2023
A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 InhibitorsWhitney Barham, Michelle Hsu, Xin Liu, et al.
BMC Cancer|October 8, 2020
Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancerAlyssa A Hoover, Demetra H Hufnagel, Whitney Harris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2016
p52 Overexpression Increases Epithelial Apoptosis, Enhances Lung Injury, and Reduces Survival after Lipopolysaccharide TreatmentJamie A Saxon, Dong-Sheng Cheng, Wei Han, et al.
Cancer Discovery|August 8, 2013
Targeting the Wnt pathway in synovial sarcoma modelsWhitney Barham, Andrea L Frump, Taylor P Sherrill, et al.
Journal for Immunotherapy of Cancer|October 28, 2025
Targeting PD-L1-CMTM6 interactions in myeloid cells triggers PD-L1 degradation and enhances cytotoxic T-cell expansionMichelle A Hsu, Xin Liu, Whitney Barham, et al.
Science Advances|June 26, 2018
Immunity drives <i>TET1</i> regulation in cancer through NF-κBEvelyne Collignon, Annalisa Canale, Clémence Al Wardi, et al.
Pageof 3